GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Omega Healthcare Investors Inc (NYSE:OHI) » Definitions » Research & Development

OHI (Omega Healthcare Investors) Research & Development : $0 Mil (TTM As of Sep. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Omega Healthcare Investors Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Omega Healthcare Investors's Research & Development for the three months ended in Sep. 2024 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $0 Mil.

Omega Healthcare Investors Research & Development Historical Data

The historical data trend for Omega Healthcare Investors's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omega Healthcare Investors Research & Development Chart

Omega Healthcare Investors Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Omega Healthcare Investors Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Omega Healthcare Investors Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omega Healthcare Investors  (NYSE:OHI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Omega Healthcare Investors Research & Development Related Terms

Thank you for viewing the detailed overview of Omega Healthcare Investors's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Omega Healthcare Investors Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Omega Healthcare Investors Inc (NYSE:OHI) » Definitions » Research & Development
Comparable Companies
DOC HR CTRE AHR SBRA NHI MPW LTC SILA DHC WELL VTR TSX:CSH.UN XBRU:AED XBRU:COFB SGX:C2PU LSE:PHP LSE:AGR TSX:NWH.UN NZSE:VHP
Traded in Other Exchanges
0KBL:UK WX4:Germany WX4:Germany
Address
303 International Circle, Suite 200, Hunt Valley, MD, USA, 21030
Website
https://www.omegahealthcare.com
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).
Executives
Daniel J Booth officer: Chief Operating Officer 9690 DEERECO ROAD, SUITE 100, TIMONIUM MD 21093
Robert O Stephenson officer: Chief Financial Officer C/O OMEGA HEALTHCARE INVESTORS, 9690 DEERECO ROAD, SUITE 100, TIMONIUM MD 21093
Lisa Egbuonu-davis director C/O OMEGA HEALTHCARE INVESTORS, INC., 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY MD 21030
Gail D Makode officer: Chief Legal Officer ONE SOUND SHORE DR, SUITE 304, GREENWICH CT 06830
Kapila K Anand director C/O EXTENDED STAY AMERICA, INC., 11525 N. COMMUNITY HOUSE ROAD, SUITE 100, CHARLOTTE NC 28277
Neal Ballew officer: Chief Accounting Officer 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY MD 21030
Burke W Whitman director 13455 NOEL ROAD # 2000, DALLAS TX 75240
Steven J Insoft officer: Chief Corp Development Officer
C Taylor Pickett director, officer: Chief Executive Officer C/O CORPORATE OFFICE PROPERTIES TRUST, 6711 COLUMBIA GATEWAY DRIVE, #300, COLUMBIA MD 21046
Kevin J Jacobs director 7930 JONES BRANCH DRIVE, MCLEAN VA 22102
Michael Ritz officer: Chief Accounting Officer 9690 DEERECO ROAD, SUITE 100, TIMONIUM MD 21131
Craig R Callen director 7902 WESTPARK DR, C/O SUNRISE ASSISTED LIVING, MCLEAN VA 22102
Ben W Perks director
Bernard J Korman director OMEGA HEALTHCARE INVESTORS INC, ANN ARBOR MI 48108
Craig M Bernfield director 303 WEST MADISON STREET, SUITE 2400, CHICAGO IL 60606